Correlation Between MeVis Medical and LEROY SEAFOOD

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MeVis Medical and LEROY SEAFOOD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MeVis Medical and LEROY SEAFOOD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MeVis Medical Solutions and LEROY SEAFOOD GRUNSPADR, you can compare the effects of market volatilities on MeVis Medical and LEROY SEAFOOD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MeVis Medical with a short position of LEROY SEAFOOD. Check out your portfolio center. Please also check ongoing floating volatility patterns of MeVis Medical and LEROY SEAFOOD.

Diversification Opportunities for MeVis Medical and LEROY SEAFOOD

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between MeVis and LEROY is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding MeVis Medical Solutions and LEROY SEAFOOD GRUNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LEROY SEAFOOD GRUNSPADR and MeVis Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MeVis Medical Solutions are associated (or correlated) with LEROY SEAFOOD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LEROY SEAFOOD GRUNSPADR has no effect on the direction of MeVis Medical i.e., MeVis Medical and LEROY SEAFOOD go up and down completely randomly.

Pair Corralation between MeVis Medical and LEROY SEAFOOD

Assuming the 90 days trading horizon MeVis Medical is expected to generate 1.39 times less return on investment than LEROY SEAFOOD. But when comparing it to its historical volatility, MeVis Medical Solutions is 1.26 times less risky than LEROY SEAFOOD. It trades about 0.06 of its potential returns per unit of risk. LEROY SEAFOOD GRUNSPADR is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  785.00  in LEROY SEAFOOD GRUNSPADR on December 20, 2024 and sell it today you would earn a total of  45.00  from holding LEROY SEAFOOD GRUNSPADR or generate 5.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MeVis Medical Solutions  vs.  LEROY SEAFOOD GRUNSPADR

 Performance 
       Timeline  
MeVis Medical Solutions 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MeVis Medical Solutions are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, MeVis Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
LEROY SEAFOOD GRUNSPADR 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in LEROY SEAFOOD GRUNSPADR are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain essential indicators, LEROY SEAFOOD may actually be approaching a critical reversion point that can send shares even higher in April 2025.

MeVis Medical and LEROY SEAFOOD Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MeVis Medical and LEROY SEAFOOD

The main advantage of trading using opposite MeVis Medical and LEROY SEAFOOD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MeVis Medical position performs unexpectedly, LEROY SEAFOOD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LEROY SEAFOOD will offset losses from the drop in LEROY SEAFOOD's long position.
The idea behind MeVis Medical Solutions and LEROY SEAFOOD GRUNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine